Peptide Therapeutics Market
Peptide Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
230
Base Year:
2023
Feb - 2024
Format:
Report Code:
VMR-2350
Segments Covered
By
Type Branded Peptides, Generic Peptides
-
By
Application Metabolic Disorders, Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, Pain Management, Rental Disorders, Dermatology, Other Applications
-
By
Route of Administration Parenteral, Oral, Other Routes of Administration
-
By
Manufacturer Type In-house, Outsourced
-
By
Synthesis Technology Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), Hybrid Technology
-
By
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 43.04 Billion |
 Revenue 2032:
|
USD 81.48 Billion |
 Revenue CAGR
(2024 - 2032): |
7.35% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Peptide Therapeutics Market Segment Analysis
- Peptide Therapeutics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Branded Peptides
- Generic Peptides
- Peptide Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Peptide Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Parenteral
- Oral
- Other Routes of Administration
- Peptide Therapeutics Manufacturer Type Outlook (Revenue, USD Million, 2018 - 2030)
- In-house
- Outsourced
- Peptide Therapeutics Synthesis Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Peptide Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
-
North America Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
-
North America Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
-
North America Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
-
North America Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
-
North America Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S.
- U.S. Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- U.S. Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- U.S. Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- U.S. Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- U.S. Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- U.S. Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S. Peptide Therapeutics Market, by Type
- Canada
- Canada Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Canada Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Canada Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Canada Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Canada Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Canada Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Canada Peptide Therapeutics Market, by Type
-
Mexico
- Mexico Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Mexico Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Mexico Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Mexico Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Mexico Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Mexico Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Mexico Peptide Therapeutics Market, by Type
-
North America Peptide Therapeutics Market, by Type
- Europe
-
Europe Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
-
Europe Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
-
Europe Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
-
Europe Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
-
Europe Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
-
Europe Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U. K.
- U.K. Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- U.K. Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- U.K. Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- U.K. Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- U.K. Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- U.K. Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.K. Peptide Therapeutics Market, by Type
- France
- France Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- France Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- France Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- France Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- France Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- France Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- France Peptide Therapeutics Market, by Type
-
Germany
- Germany Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Germany Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Germany Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Germany Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Germany Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Germany Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Peptide Therapeutics Market, by Type
-
Italy
- Italy Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Italy Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Italy Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Italy Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Italy Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Italy Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Italy Peptide Therapeutics Market, by Type
-
Spain
- Spain Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Spain Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Spain Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Spain Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Spain Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Spain Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Spain Peptide Therapeutics Market, by Type
-
Rest of Europe
- Rest of Europe Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Rest of Europe Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Rest of Europe Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Rest of Europe Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Rest of Europe Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Rest of Europe Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Europe Peptide Therapeutics Market, by Type
-
Europe Peptide Therapeutics Market, by Type
- Asia Pacific
-
Asia Pacific Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
-
Asia Pacific Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
-
Asia Pacific Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
-
Asia Pacific Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
-
Asia Pacific Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
-
Asia Pacific Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China
- China Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- China Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- China Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- China Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- China Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- China Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China Peptide Therapeutics Market, by Type
- Japan
- Japan Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Japan Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Japan Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Japan Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Japan Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Japan Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Japan Peptide Therapeutics Market, by Type
-
Germany
- Germany Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Germany Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Germany Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Germany Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Germany Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Germany Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Peptide Therapeutics Market, by Type
-
India
- India Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- India Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- India Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- India Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- India Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- India Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- India Peptide Therapeutics Market, by Type
-
South Korea
- South Korea Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- South Korea Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- South Korea Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- South Korea Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- South Korea Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- South Korea Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Korea Peptide Therapeutics Market, by Type
-
South East Asia
- South East Asia Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- South East Asia Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- South East Asia Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- South East Asia Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- South East Asia Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- South East Asia Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South East Asia Peptide Therapeutics Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Rest of Asia Pacific Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Rest of Asia Pacific Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Rest of Asia Pacific Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Rest of Asia Pacific Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Rest of Asia Pacific Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Asia Pacific Peptide Therapeutics Market, by Type
-
Asia Pacific Peptide Therapeutics Market, by Type
- Latin America
-
Latin America Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
-
Latin America Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
-
Latin America Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
-
Latin America Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
-
Latin America Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
-
Latin America Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil
- Brazil Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Brazil Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Brazil Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Brazil Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Brazil Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Brazil Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil Peptide Therapeutics Market, by Type
- Argentina
- Argentina Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Argentina Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Argentina Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Argentina Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Argentina Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Argentina Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Argentina Peptide Therapeutics Market, by Type
-
Rest of Latin America
- Rest of Latin America Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Rest of Latin America Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Rest of Latin America Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Rest of Latin America Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Rest of Latin America Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Rest of Latin America Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Latin America Peptide Therapeutics Market, by Type
-
Latin America Peptide Therapeutics Market, by Type
- Middle East & Africa
-
Middle East & Africa Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
-
Middle East & Africa Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
-
Middle East & Africa Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
-
Middle East & Africa Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
-
Middle East & Africa Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
-
Middle East & Africa Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries
- GCC Countries Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- GCC Countries Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- GCC Countries Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- GCC Countries Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- GCC Countries Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- GCC Countries Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries Peptide Therapeutics Market, by Type
- South Africa
- South Africa Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- South Africa Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- South Africa Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- South Africa Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- South Africa Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- South Africa Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Africa Peptide Therapeutics Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Peptide Therapeutics Market, by Type
- Branded Peptides
- Generic Peptides
- Rest of Middle East & Africa Peptide Therapeutics Market, by Application
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Pain Management
- Rental Disorders
- Dermatology
- Other Applications
- Rest of Middle East & Africa Peptide Therapeutics Market, by Route of Administration
- Parenteral
- Oral
- Other Routes of Administration
- Rest of Middle East & Africa Peptide Therapeutics Market, by Manufacturer Type
- In-house
- Outsourced
- Rest of Middle East & Africa Peptide Therapeutics Market, by Synthesis Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Rest of Middle East & Africa Peptide Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Middle East & Africa Peptide Therapeutics Market, by Type
-
Middle East & Africa Peptide Therapeutics Market, by Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Peptide Therapeutics in terms of revenue?
-
The global Peptide Therapeutics valued at USD 43.04 Billion in 2023 and is expected to reach USD 81.48 Billion in 2032 growing at a CAGR of 7.35%.
Which are the prominent players in the market?
-
The prominent players in the market are Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Amgen Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), AstraZeneca PLC (UK), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Ironwood Pharmaceuticals Inc. (U.S.), Radius Health Inc. (U.S.), Ipsen Pharma (France).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.35% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Peptide Therapeutics include
- Advancements in Production Processes Driving Growth
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Peptide Therapeutics in 2023.
